Posted November 5, 2026 | Reviewed by Jessica Schrader “We all do better when we all do better,” according to Paul Wellstone, one of my college professors and a former U.S. senator. These are times of uncertainty, volatility, lack of standards in…
For Silvia Cerolini, a patient advocate and mother of a daughter living with a rare disease, that experience captures one of the most frustrating contradictions in rare disease drug development. Scientific progress can bring a potential treatment remarkably far, only…
1. In adult patients in the intensive care unit (ICU) requiring venous access following central venous catheter (CVC) removal, midline catheters (MCs) were associated with lower catheter-related bloodstream infection (CRBSI) rates but higher chances of premature removal compared with peripherally inserted central…
This month has been marked by progress in both the regulatory and investment sides of rejuvenation biotechnology. For years, the field has faced two major challenges: scientific advances outpacing the regulatory systems meant to evaluate them, and a capital environment…
Millions of Americans are turning to GLP-1 medications for weight loss, but as the drugs become more popular and more options emerge online, the Washington Poison Center says it is seeing a sharp rise in calls involving the medications. Between…
Bioethicist Jeremy Sugarman has outlined a seven-criterion ethical framework to guide the assessment, oversight, and conduct of basic stem cell-related research.
Italians believe in clinical research, but find it difficult to understand what it is and to imagine themselves taking part in a trial. This is the picture that emerges from the survey ‘Value, perception and impact of clinical research in…
Buerger's Disease Market is Projected to Evolve by 2036 Owing openPR.com Buerger's Disease Market is Projected to Evolve by 2036 Owing to the Growing Focus on Vascular Regeneration and Emerging Therapeutic Approaches | DelveInsight Press release from: ABNewswire Permanent link to this…
A post-hoc analysis of a French and Italian trial found that early discomfort on noninvasive support and solid cancer were independently linked to ICU death in immunocompromised patients, while pre-admission performance status drove poor six-month outcomes among survivors.
Posted Nov 5th, 2026 Brock University students Brooke Latour (left) and Avinder Saini participated in Canadian Patient Safety Week activities through the I-EQUIP program, which supports Niagara Health's commitment to safe, high-quality care. When Brooke Latour first thought about patient safety, she…
Safer care through checklists, culture, measurement, infection control, and ethics.
An article joins this feed when it matches these terms. Each one is also a search of its own.